Buscar
Mostrando ítems 1-10 de 71
Identifying Patients With Pharmacoresistant Epilepsy Using A Plasma-based Test
(WILEY-BLACKWELLHOBOKEN, 2015)
Brain Atrophy In Seizure-free Temporal Lobe Epilepsy: Implications For Predicting Pharmacoresistance
(Wiley-BlackwellHoboken, 2016)
Seizures triggered by pentylenetetrazol in marmosets made chronically epileptic with pilocarpine show greater refractoriness to treatment
(Elsevier Science Bv, 2016)
The efficiency of most of the new antiepileptic drugs (AEDs) on clinical trials still falls short the success reported in pre-clinical studies, possibly because the validity of the animal models is insufficient to fully ...
Transporter hypothesis in pharmacoresistant epilepsies Is it at the central or peripheral level?
(John Wiley & Sons Inc., 2021-09)
The multidrug resistance (MDR) phenotype is typically observed in patients with refractory epilepsy (RE) whose seizures are not controlled despite receiving several combinations of more than two antiseizure medications ...
New model of pharmacoresistant seizures induced by 3-mercaptopropionic acid in mice
(Elsevier Science, 2017-01)
About 30% of the patients with epilepsy do not respond to clinically established anticonvulsants, despite having effective concentrations of the antiepileptic drug in plasma. Therefore, new preclinical models of epilepsy ...
To what extent does depression in fl uence quality of life of people with pharmacoresistant epilepsy in Argentina?
(Academic Press Inc Elsevier Science, 2017-03)
Depression is the most frequent psychiatric co-morbidity in patients with epilepsy. Lifetime prevalence of depression is reported more frequently in temporal lobe epilepsy and is estimated at 35%. This comorbidity appears ...